—
no predictions resolved yet
0 pending · 0 expired
1
companies · 3 data points
We're doing a deal about every two weeks. Most of them are smallish.
We've committed with President Trump to build all that in the U.S. We're currently constructing six plants. We're going to announce four more in the next six months. We're hoping to be able to announce one today, but they'll come in a few weeks. So, yeah, this is creating 20,000 construction jobs in this period and ultimately 5,000 or 6,000 manufacturing jobs. And so we'll become a net exporter at scale for these. And unless some Chinese state-owned enterprise gets in this business, it'll be ver
So first priority, invest in organic R&D. Secondly, build out the supply chain. What's different about Manjaro and the follow-on drugs is they're injectable drugs. These are very capital intensive, technically difficult things to scale.